A significant shift in Canadian drug policy has occurred, as the government allow the use of psilocybin hallucinogens for therapeutic applications. Until now, these substances were heavily restricted, but a mounting body of studies suggests they could offer aid for mental health illnesses like PTSD. This change represents a major step toward recons